Therefore, we treated YM-positive ES-2 cells along with YM-negative Heya-8 cells and mucoepidermoid carcinoma H3118 cells, which carry the CRTC1-MAML2 fusion, with two such inhibitors: verteporfin (VPF) and CA3. Here, CRTC1 is linked to mucoepidermoid carcinoma.